Akeso Biopharma

Akeso Biopharma

康方生物

Akeso Biopharma

Biotech/Healthcare

Kangfang Biopharma (Akeso) is an innovative developer of new antibody drugs—a biopharmaceutical company focused on antibody and protein drug development, committed to discovering and developing innovative antibody medicines with independently held intellectual property rights. It is a subsidiary of…

Latest round: Post-IPO (2024)

Source: ChinaBulls — chinabulls.com

Last updated 2024-10-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.